AstraZeneca Koselugo gets Chinese nod for paediatric patients with neurofibromatosis type 1, plexiform neurofibromas Ruchika Sharma9 May 2023 12:30 PM ISTIn addition to China, Koselugo is also approved in the US, EU, Japan and several other countries for the treatment of paediatric patients with NF1 and...
Selumetinib safe option for treatment of inoperable plexiform neurofibromas Medical Dialogues Editorial Team7 Jun 2022 12:15 PM ISTSelumetinib is a medication that is both effective and safe for young patients having symptomatic, inoperable plexiform neurofibromas, says an article...
AstraZeneca Pharma India bags DCGI nod to import and market Selumetinib capsules Ruchika Sharma27 Sept 2021 4:02 PM ISTNew Delhi: Drugmaker, AstraZeneca Pharma India Limited, has recently announced that the company has received import and market permission in Form...
Study demonstrates efficacy of new treatment for neurofibromatosis type 1-related tumors Hina Zahid24 Jan 2021 10:39 PM ISTPhiladelphia: Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children's Hospital of...
